Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes
Ultrasound Guided Detection and Characterization of Subclinical Lipohypertrophy in Type 1 and Type 2 Diabetes Mellitus
Sponsor: University of British Columbia
Terminated
The study run its course
Other terminated trials from University of British Columbia
Listed as NCT02348099, this observational or N/A phase trial focuses on Diabetes and Lipohypertrophy and remains terminated or withdrawn. Sponsored by University of British Columbia, it has been updated 13 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Jun 2025 — Present [monthly]
Terminated
Status: Suspended → Terminated
-
May 2025 — Jun 2025 [monthly]
Suspended
Status: Unknown → Suspended
-
Sep 2024 — May 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2022 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Oct 2019 — Apr 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .